West Pharmaceutical Services Net Income 2010-2024 | WST

West Pharmaceutical Services annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • West Pharmaceutical Services net income for the quarter ending March 31, 2024 was $0.115B, a 17.64% decline year-over-year.
  • West Pharmaceutical Services net income for the twelve months ending March 31, 2024 was $0.569B, a 3.01% increase year-over-year.
  • West Pharmaceutical Services annual net income for 2023 was $0.593B, a 1.28% increase from 2022.
  • West Pharmaceutical Services annual net income for 2022 was $0.586B, a 11.47% decline from 2021.
  • West Pharmaceutical Services annual net income for 2021 was $0.662B, a 91.16% increase from 2020.
West Pharmaceutical Services Annual Net Income
(Millions of US $)
2023 $593
2022 $586
2021 $662
2020 $346
2019 $242
2018 $207
2017 $151
2016 $144
2015 $96
2014 $127
2013 $112
2012 $81
2011 $76
2010 $65
2009 $73
West Pharmaceutical Services Quarterly Net Income
(Millions of US $)
2024-03-31 $115
2023-12-31 $137
2023-09-30 $161
2023-06-30 $155
2023-03-31 $140
2022-12-31 $103
2022-09-30 $121
2022-06-30 $189
2022-03-31 $174
2021-12-31 $148
2021-09-30 $176
2021-06-30 $187
2021-03-31 $151
2020-12-31 $98
2020-09-30 $82
2020-06-30 $91
2020-03-31 $74
2019-12-31 $64
2019-09-30 $56
2019-06-30 $66
2019-03-31 $55
2018-12-31 $52
2018-09-30 $55
2018-06-30 $56
2018-03-31 $44
2017-12-31 $0
2017-09-30 $51
2017-06-30 $39
2017-03-31 $61
2016-12-31 $39
2016-09-30 $38
2016-06-30 $45
2016-03-31 $22
2015-12-31 $33
2015-09-30 $2
2015-06-30 $28
2015-03-31 $33
2014-12-31 $31
2014-09-30 $31
2014-06-30 $38
2014-03-31 $27
2013-12-31 $24
2013-09-30 $27
2013-06-30 $30
2013-03-31 $32
2012-12-31 $21
2012-09-30 $15
2012-06-30 $16
2012-03-31 $29
2011-12-31 $19
2011-09-30 $17
2011-06-30 $20
2011-03-31 $20
2010-12-31 $6
2010-09-30 $18
2010-06-30 $22
2010-03-31 $20
2009-12-31 $20
2009-09-30 $17
2009-06-30 $20
2009-03-31 $15
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $26.385B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.394B 19.11
Becton Dickinson (BDX) United States $66.895B 19.43
Cardinal Health (CAH) United States $25.104B 15.09
Align Technology (ALGN) United States $23.254B 44.92
Cooper (COO) United States $17.657B 26.72
Labcorp (LH) United States $16.691B 14.40
Henry Schein (HSIC) United States $9.396B 16.25
DENTSPLY SIRONA (XRAY) United States $6.339B 16.70
Merit Medical Systems (MMSI) United States $4.284B 24.51
Patterson (PDCO) United States $2.309B 11.06
STAAR Surgical (STAA) United States $2.307B 72.25
CONMED (CNMD) United States $2.025B 18.37
Atrion (ATRI) United States $0.695B 35.81
Lifevantage (LFVN) United States $0.080B 12.89
Pro-Dex (PDEX) United States $0.066B 24.91
Biolase (BIOL) United States $0.005B 0.00